Case Reports in Obstetrics and Gynecology

Case Reports in Obstetrics and Gynecology / 2014 / Article

Retraction | Open Access

Volume 2014 |Article ID 674953 | 1 page | https://doi.org/10.1155/2014/674953

Retracted: Intravenous Leiomyoma with Extension to the Heart: A Case Report and Review of the Literature

Received22 Jul 2014
Accepted22 Jul 2014
Published03 Aug 2014

The article titled “Intravenous Leiomyoma with Extension to the Heart: A Case Report and Review of the Literature” [1], published in Case Reports in Obstetrics and Gynecology, has been retracted as it is found to contain a substantial amount of material, without referencing, from the published article titled “Surgical management of intravenous leiomyoma with cardiac extension. Do we need total circulatory arrest?” by S. Senay, U. Kaya, H. Cagil, F. Demirkiran, C. Alhan, The Thoracic and Cardiovascular Surgeon 2007; 55(5): 322-323. DOI: 10.1055/s-2007-964953. Also, the article was submitted for publication by Veysel Sal without the knowledge and approval of the coauthors Umit Kaya and Cem Alhan.

References

  1. F. Demirkiran, V. Sal, K. Umit, C. Alhan, and N. Tokgozoglu, “Intravenous leiomyoma with extension to the heart: a case report and review of the literature,” Case Reports in Obstetrics and Gynecology, vol. 2013, Article ID 602407, 3 pages, 2013. View at: Publisher Site | Google Scholar

Copyright © 2014 Case Reports in Obstetrics and Gynecology. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

632 Views | 311 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.